Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gex-Fabry

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Therapeutic Drug Monitoring|February 1, 1997
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medicationM Gex-Fabry, A E Balant-Gorgia, L P Balant
Therapeutic Drug Monitoring|February 1, 1995
Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemideM Gex-Fabry, A E Balant-Gorgia, L P Balant
Clinical Pharmacokinetics|June 1, 1991
Clinical pharmacokinetics of clomipramineA E Balant-Gorgia, M Gex-Fabry, L P Balant
Therapeutic Drug Monitoring|March 2, 1999
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factorsA E Balant-Gorgia, M Gex-Fabry, C Genet, et al.
L'Encephale|April 25, 2006
[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population]A Zanello, B Weber Rouget, M Gex-Fabry, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1987
Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patientsA E Balant-Gorgia, L P Balant, M Gex-Fabry, et al.
Therapeutic Drug Monitoring|April 1, 1992
Persistent impairment of clomipramine demethylation in recently detoxified alcoholic patientsA E Balant-Gorgia, M Gay, M Gex-Fabry, et al.
Nordic Journal of Psychiatry|April 26, 2006
Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic statesP Bech, M Gex-Fabry, J-M Aubry, et al.
Clinical Pharmacokinetics|September 1, 1990
Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring dataM Gex-Fabry, A E Balant-Gorgia, L P Balant, et al.
Therapeutic Drug Monitoring|April 1, 1994
Clomipramine therapy in the geriatric hospital: experience with therapeutic drug monitoringJ P Bocksberger, M Gex-Fabry, L Gauthey, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|February 1, 1997
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medicationM Gex-Fabry, A E Balant-Gorgia, L P Balant
Therapeutic Drug Monitoring|February 1, 1995
Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemideM Gex-Fabry, A E Balant-Gorgia, L P Balant
Clinical Pharmacokinetics|June 1, 1991
Clinical pharmacokinetics of clomipramineA E Balant-Gorgia, M Gex-Fabry, L P Balant
Therapeutic Drug Monitoring|March 2, 1999
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factorsA E Balant-Gorgia, M Gex-Fabry, C Genet, et al.
L'Encephale|April 25, 2006
[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population]A Zanello, B Weber Rouget, M Gex-Fabry, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1987
Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patientsA E Balant-Gorgia, L P Balant, M Gex-Fabry, et al.
Therapeutic Drug Monitoring|April 1, 1992
Persistent impairment of clomipramine demethylation in recently detoxified alcoholic patientsA E Balant-Gorgia, M Gay, M Gex-Fabry, et al.
Nordic Journal of Psychiatry|April 26, 2006
Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic statesP Bech, M Gex-Fabry, J-M Aubry, et al.
Clinical Pharmacokinetics|September 1, 1990
Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring dataM Gex-Fabry, A E Balant-Gorgia, L P Balant, et al.
Therapeutic Drug Monitoring|April 1, 1994
Clomipramine therapy in the geriatric hospital: experience with therapeutic drug monitoringJ P Bocksberger, M Gex-Fabry, L Gauthey, et al.
Pageof 6